Joseph Monsonégo

3.8k total citations
70 papers, 2.5k citations indexed

About

Joseph Monsonégo is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Joseph Monsonégo has authored 70 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 25 papers in Surgery and 16 papers in Oncology. Recurrent topics in Joseph Monsonégo's work include Cervical Cancer and HPV Research (61 papers), Genital Health and Disease (16 papers) and Global Cancer Incidence and Screening (13 papers). Joseph Monsonégo is often cited by papers focused on Cervical Cancer and HPV Research (61 papers), Genital Health and Disease (16 papers) and Global Cancer Incidence and Screening (13 papers). Joseph Monsonégo collaborates with scholars based in France, United States and Canada. Joseph Monsonégo's co-authors include Eduardo L. Franco, Laurent Zerat, Silvia Franceschi, Karí Syrjänen, Oliver Bautista, Scott Vuocolo, Janine T. Bryan, Kevin A. Ault, Richard M. Haupt and Anna R. Giuliano and has published in prestigious journals such as The Lancet, American Journal of Obstetrics and Gynecology and British Journal of Cancer.

In The Last Decade

Joseph Monsonégo

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Monsonégo France 22 2.2k 1.0k 468 348 326 70 2.5k
François Coutlée Canada 27 2.6k 1.2× 1.6k 1.5× 535 1.1× 340 1.0× 366 1.1× 86 3.2k
John Schussler United States 19 1.9k 0.8× 794 0.8× 327 0.7× 301 0.9× 289 0.9× 35 2.0k
Jeanne M. Pimenta United Kingdom 19 2.3k 1.0× 1.4k 1.4× 309 0.7× 169 0.5× 443 1.4× 55 2.9k
Mónica Molano Colombia 18 2.4k 1.1× 1.3k 1.2× 369 0.8× 287 0.8× 708 2.2× 50 2.8k
Paulo Naud Brazil 20 2.2k 1.0× 812 0.8× 456 1.0× 281 0.8× 248 0.8× 49 2.7k
Hugo De Vuyst France 24 2.4k 1.1× 1.2k 1.2× 878 1.9× 138 0.4× 303 0.9× 49 2.7k
Leah Beardsley United States 7 2.0k 0.9× 996 1.0× 328 0.7× 226 0.6× 381 1.2× 8 2.3k
Rajamanickam Rajkumar France 13 2.2k 1.0× 758 0.7× 892 1.9× 168 0.5× 284 0.9× 25 2.5k
Stuart I. Collins United Kingdom 20 1.6k 0.7× 890 0.9× 420 0.9× 557 1.6× 263 0.8× 30 2.5k
Júlio César Teixeira Brazil 18 1.9k 0.9× 750 0.7× 335 0.7× 209 0.6× 202 0.6× 69 2.4k

Countries citing papers authored by Joseph Monsonégo

Since Specialization
Citations

This map shows the geographic impact of Joseph Monsonégo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Monsonégo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Monsonégo more than expected).

Fields of papers citing papers by Joseph Monsonégo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Monsonégo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Monsonégo. The network helps show where Joseph Monsonégo may publish in the future.

Co-authorship network of co-authors of Joseph Monsonégo

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Monsonégo. A scholar is included among the top collaborators of Joseph Monsonégo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Monsonégo. Joseph Monsonégo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madathil, Sreenath, et al.. (2025). A multimodal deep learning model for cervical pre-cancers and cancers prediction: Development and internal validation study. Computers in Biology and Medicine. 186. 109710–109710. 1 indexed citations
2.
Huh, Warner K., Catherine Behrens, Joseph Monsonégo, et al.. (2015). Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine. Gynecologic Oncology. 137. 16–16. 1 indexed citations
3.
Giuliano, Anna R., Alan G. Nyitray, Aimée R. Kreimer, et al.. (2014). EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection. International Journal of Cancer. 136(12). 2752–2760. 225 indexed citations
4.
Monsonégo, Joseph, et al.. (2013). Prévalence des génotypes d’HPV chez les femmes en France : implications pour le dépistage et la vaccination. Gynécologie Obstétrique & Fertilité. 41(5). 305–313. 3 indexed citations
5.
6.
Monsonégo, Joseph. (2012). Cervical Cancer Prevention – Current Perspectives. Endocrine development. 22. 222–229. 4 indexed citations
7.
Nicol, Alcina F. & Joseph Monsonégo. (2011). Summary of the Eurogin 2011 conference: Highlighting the recent advances in HPV-related cancers. Gynecologic Oncology. 123(2). 179–181. 2 indexed citations
8.
Monsonégo, Joseph. (2010). Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin. Gynécologie Obstétrique & Fertilité. 38(4). 250–254. 2 indexed citations
9.
Monsonégo, Joseph, Michael G. Hudgens, Laurent Zerat, et al.. (2010). Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study. International Journal of Cancer. 129(3). 691–701. 115 indexed citations
10.
Muñóz, Nubia, Punee Pitisuttithum, Damrong Tresukosol, et al.. (2009). Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial. The Lancet. 373(9679). 1949–1957. 362 indexed citations
11.
Monsonégo, Joseph, J. Gabrielle Breugelmans, S. Bouée, et al.. (2007). Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France. Gynécologie Obstétrique & Fertilité. 35(2). 107–113. 52 indexed citations
12.
13.
Monsonégo, Joseph, Javier Pintos, Caroline Semaille, et al.. (2006). Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. International Journal of Gynecological Cancer. 16(2). 591–598. 20 indexed citations
14.
Monsonégo, Joseph. (2006). EUROGIN 2006 expert consensus report. Gynecologic Oncology. 103(1). 7–7. 3 indexed citations
15.
Halioua, Bruno, et al.. (2006). Ano-rectal lymphogranuloma venereum: 22 cases reported in a sexually transmited infections center in Paris.. PubMed. 16(2). 177–80. 17 indexed citations
16.
Lafuma, A, Joseph Monsonégo, M. Moyal‐Barracco, & C. Pribil. (2004). [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].. PubMed. 130(8-9 Pt 1). 731–6. 10 indexed citations
17.
Monsonégo, Joseph, et al.. (1997). Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia. BJOG An International Journal of Obstetrics & Gynaecology. 104(6). 723–727. 13 indexed citations
18.
Monsonégo, Joseph. (1996). Pathogénie cellulaire et moléculaire du cancer du col.. médecine/sciences. 12(6-7). 733–733. 3 indexed citations
19.
Monsonégo, Joseph. (1995). [Cellular and molecular pathogenesis of cancer of the cervix].. PubMed. 23(12). 731–40. 2 indexed citations
20.
Monsonégo, Joseph, et al.. (1991). Fibrocystic disease of the breast in premenopausal women: Histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment. American Journal of Obstetrics and Gynecology. 164(5). 1181–1189. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Coutlée Breakdown of academic impact, for papers by John Schussler Breakdown of academic impact, for papers by Jeanne M. Pimenta Breakdown of academic impact, for papers by Mónica Molano Breakdown of academic impact, for papers by Paulo Naud Breakdown of academic impact, for papers by Hugo De Vuyst Breakdown of academic impact, for papers by Leah Beardsley Breakdown of academic impact, for papers by Rajamanickam Rajkumar Breakdown of academic impact, for papers by Stuart I. Collins Breakdown of academic impact, for papers by Júlio César Teixeira
Rankless by CCL
2026